GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
Incyte Corporation
Incyte Corporation
Fred Hutchinson Cancer Center
Stanford University
IGF Oncology, LLC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Fred Hutchinson Cancer Center
Magenta Therapeutics, Inc.
Fred Hutchinson Cancer Center
CTI BioPharma
Jonsson Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
New York Blood Center
Stanford University
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Indiana University
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
University of Rochester
Ottawa Hospital Research Institute
University Health Network, Toronto
Merck Sharp & Dohme LLC
Indiana University
Texas Oncology Cancer Center
University of California, San Francisco
University of California, San Francisco
Skyline Diagnostics BV
The Emmes Company, LLC
Washington University School of Medicine
H. Lee Moffitt Cancer Center and Research Institute
Rutgers, The State University of New Jersey